Nuhoğlu Kantarcı, E. Et Al. 2023. Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient. Cancer , vol.129, no.17 , 2610-2612.

Nuhoğlu Kantarcı, E., Tolgay, E., & EŞKAZAN, A. E., (2023). Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient. Cancer , vol.129, no.17, 2610-2612.

Nuhoğlu Kantarcı, Eda, Ece Tolgay, And AHMET EMRE EŞKAZAN. "Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient," Cancer , vol.129, no.17, 2610-2612, 2023

Nuhoğlu Kantarcı, Eda N. Et Al. "Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient." Cancer , vol.129, no.17, pp.2610-2612, 2023

Nuhoğlu Kantarcı, E. Tolgay, E. And EŞKAZAN, A. E. (2023) . "Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient." Cancer , vol.129, no.17, pp.2610-2612.

@article{article, author={Eda Nuhoğlu Kantarcı Et Al. }, title={Fine-tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic-phase chronic myeloid leukemia: The choice of the right TKI for the right patient}, journal={Cancer}, year=2023, pages={2610-2612} }